Add like
Add dislike
Add to saved papers

[Knockdown of Alox5 gene promotes apoptosis of K562/ADM cells].

Objective To investigate the effect of short hairpin RNA (shRNA) knockdown of arachidonate 5-lipoxygenase (Alox5) gene on the apoptosis of resistant chronic myeloid leukemia K562/ADM cells. Methods Three pairs of shRNA fragment targeting human Alox5 gene were synthesized and inserted into pGenesil-1 interference vector. Enzyme digestion and sequencing were performed to identify the recombinant plasmid pGenesil-1-shRNA-Alox5. The plasmid was then transfected into K562/ADM cells. Real-time quantitative PCR and Western blotting were used to detect the Alox5 mRNA and protein levels to get the best interference group. The pGenesil-1-shRNA-Alox5 plasmid group with higher interference efficiency was selected as the experimental subjects. Real-time quantitative PCR was adopted to detect the expression level of bcr/abl mRNA and Western blotting to detect the BCR/ABL fusion protein, and the apoptotic rate was assessed by flow cytometry. Results The enzyme digestion and sequencing confirmed the successful construction of recombinant plasmid. Compared with the negative pGenesil-1-K562/ADM control group and blank K562/ADM cell group, the Alox5 mRNA and protein levels of K562/ADM cells transfected with pGenesil-1-shRNA-Alox5 recombinant plasmid significantly decreased, and after the knockdown of Alox5, the levels of bcr/abl mRNA and BCR/ABL fusion protein significantly decreased and the apoptosis rate increased obviously. Conclusion The knockdown of Alox5 gene can induce the decreased levels of bcl/abl mRNA and BCR/ABL fusion protein in the K562/ADM cells and increased apoptosis rate.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app